Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion
Risk factors indicate the importance of oxidative stress during ovarian carcinogenesis. To tolerate oxidative stress, cells activate the transcription factor Nrf2 (Nfe2l2), the master regulator of antioxidant and cytoprotective genes. Indeed, for most cancers, hyperactivity of Nrf2 is observed, and siRNA studies assigned Nrf2 as therapeutic target. However, the cancer-protective role of Nrf2 in healthy cells highlights the requirement for an adequate therapeutic window. We engineered artificial transcription factors to assess the role of Nrf2 in healthy (OSE-C2) and malignant ovarian cells (A2780).
Source: Molecular Oncology - Category: Cancer & Oncology Authors: Monique G.P. van der Wijst, Christian Huisman, Archibold Mposhi, Gerard Roelfes, Marianne G. Rots Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Hyperactivity | Ovarian Cancer | Ovaries | Study